May 21, 2003
Teva Pharmaceuticals Has Recalled
Enalapril Maleate Tablets
The Food and Drug Administration (FDA) released the following information.
Enalapril Maleate Tablets, USP, 10 mg, bottles of 1000, TEVA, Rx only.
Recall # D-247-3.
Lot # 15741 exp 5/31/03.
Teva Pharmaceuticals USA, North Wales, PA, by letters dated March 19, 2003.
Firm initiated recall is
Degradation: Related compound specification failure (18 month stability).
VOLUME OF PRODUCT IN COMMERCE